Explore

39THAMEBJS2021

39th Annual Meeting of the European Bone and Joint Society 2021

Exhibition and Convention Centre, Dunajska cesta 18, Ljubljana, Ljubljana, 1000, Slovenia
7 - 9 October 2021
The conference ended on 09 October 2021

Important Dates

Abstract Submission Deadline
6th October 2021

About 39THAMEBJS2021

The 39th Annual Meeting of the European Bone and Joint Infection Society will take place in Ljubljana, Slovenia on 7-9 October 2021.

Topics

Health

Call for Papers

The conference will bring together experts, practitioners and companies involved in the treatment of bone and joint infections. Professionals attending the conference will benefit from high-level scientific presentations, knowledge sharing and networking opportunities. The scientific programme will be provided with keynote lectures, free paper sessions, industry symposia and posters.

The main conference theme is: "Joining forces: optimising diagnosis and management of bone and joint infections"

The topics for EBJIS 2021 are:

Optimising antibiotic treatment of bone and joint infections (i.e., how to deal with multidrug resistant pathogens, antibiotic side-effects/complications of antibiotic treatment, when to do an oral switch, antibiotic holidays yes/no...)

Optimal bone infection sampling and microbiological processing

Low-grade PJI - what is the best approach?

Musculoskeletal infections in children

Infections of arthroscopic implants, osteotomies and tendon reconstructions

Chronic osteomyelitis with good function. To treat or to live with?

Spinal infections

Fracture-related infections

Prices: 

EBJIS members BD: EUR 558.0, 

EBJIS members AD: EUR 645.0, 

ESCMID member BD: EUR 614.0, 

ESCMID member AD: EUR 670.0, 

Non-member BD: EUR 682.0, 

Non-member AD: EUR 744.0, 

Resident BD: EUR 310.0, 

Resident AD: EUR 422.0, 

1-day reg BD: EUR 341.0, 

1-day reg AD: EUR 372.0

Time: 08:00 - 17:00

Keep Up to Date with PaperCrowd

Sign up and follow your favorite conferences.

We are no longer accepting conference submissions on PaperCrowd. We apologise for any inconvenience.